Table 2.

Cross-species intersection of plasma protein signatures of MEN1-related dpNET progression

MEN1-PanNET micea
8 month12 monthHuman MEN1 cohort
ProteinDescriptionFold-changeaFold-changeaAUCb95% CI
NDC80Kinetochore protein NDC803.584.300.840.64-1.00
DEF8Differentially expressed in FDCP 8 homolog3.583.320.770.60-0.93
SPAG17Sperm associated antigen 171.931.320.820.59-1.00
ATMATM serine/threonine kinase1.541.990.660.50-0.82
IMMTInner membrane mitochondrial protein1.362.950.770.57-0.96
DNAH6Dynein axonemal heavy chain 61.321.550.690.50-0.88
DSPDesmoplakin1.311.570.770.49-1.00
CITCitron Rho-interacting serine/threonine kinase1.226.160.750.56-0.94
C3Complement C31.161.430.670.53-0.82
HRGHistidine rich glycoprotein1.151.240.660.49-0.82
F5Coagulation factor V1.141.260.750.60-0.89
CD79ACluster of differentiation CD79A1.083.220.690.44-0.95
BDP1B double prime 11.072.860.680.53-0.84
SERPINA11Serpin family A member 111.061.440.750.60-0.90
PROS1Coagulation regulator protein S1.061.430.690.53-0.84
TARBP1TAR (HIV-1) RNA binding protein 11.051.310.840.65-1.00
B2MB2 microglobulin1.021.250.680.52-0.84
SERPIND1Serpin family D member 11.021.210.700.54-0.85
PROCProtein C1.001.230.680.53-0.84
MEN1-PanNET micea
8 month12 monthHuman MEN1 cohort
ProteinDescriptionFold-changeaFold-changeaAUCb95% CI
NDC80Kinetochore protein NDC803.584.300.840.64-1.00
DEF8Differentially expressed in FDCP 8 homolog3.583.320.770.60-0.93
SPAG17Sperm associated antigen 171.931.320.820.59-1.00
ATMATM serine/threonine kinase1.541.990.660.50-0.82
IMMTInner membrane mitochondrial protein1.362.950.770.57-0.96
DNAH6Dynein axonemal heavy chain 61.321.550.690.50-0.88
DSPDesmoplakin1.311.570.770.49-1.00
CITCitron Rho-interacting serine/threonine kinase1.226.160.750.56-0.94
C3Complement C31.161.430.670.53-0.82
HRGHistidine rich glycoprotein1.151.240.660.49-0.82
F5Coagulation factor V1.141.260.750.60-0.89
CD79ACluster of differentiation CD79A1.083.220.690.44-0.95
BDP1B double prime 11.072.860.680.53-0.84
SERPINA11Serpin family A member 111.061.440.750.60-0.90
PROS1Coagulation regulator protein S1.061.430.690.53-0.84
TARBP1TAR (HIV-1) RNA binding protein 11.051.310.840.65-1.00
B2MB2 microglobulin1.021.250.680.52-0.84
SERPIND1Serpin family D member 11.021.210.700.54-0.85
PROCProtein C1.001.230.680.53-0.84

Abbreviations: AUC, area under the receiver operating characteristics curve; CI, confidence interval; dpNET, duodenopancreatic neuroendocrine tumor.

aFold change comparing plasma protein levels between cases (Men1fl/flPdx1-CreTg) and control (Men1fl/fl) mice.

bPredictive performance (AUC) for distinguishing cases from respective controls. Cases are defined as patients with MEN1 and liver metastases from a duodenopancreatic neuroendocrine tumor (dpNET). Controls are patients with MEN1 and a nonmetastatic (distant or regional) indolent dpNET or patients with MEN1 without a dpNET or other neuroendocrine tumor.

Table 2.

Cross-species intersection of plasma protein signatures of MEN1-related dpNET progression

MEN1-PanNET micea
8 month12 monthHuman MEN1 cohort
ProteinDescriptionFold-changeaFold-changeaAUCb95% CI
NDC80Kinetochore protein NDC803.584.300.840.64-1.00
DEF8Differentially expressed in FDCP 8 homolog3.583.320.770.60-0.93
SPAG17Sperm associated antigen 171.931.320.820.59-1.00
ATMATM serine/threonine kinase1.541.990.660.50-0.82
IMMTInner membrane mitochondrial protein1.362.950.770.57-0.96
DNAH6Dynein axonemal heavy chain 61.321.550.690.50-0.88
DSPDesmoplakin1.311.570.770.49-1.00
CITCitron Rho-interacting serine/threonine kinase1.226.160.750.56-0.94
C3Complement C31.161.430.670.53-0.82
HRGHistidine rich glycoprotein1.151.240.660.49-0.82
F5Coagulation factor V1.141.260.750.60-0.89
CD79ACluster of differentiation CD79A1.083.220.690.44-0.95
BDP1B double prime 11.072.860.680.53-0.84
SERPINA11Serpin family A member 111.061.440.750.60-0.90
PROS1Coagulation regulator protein S1.061.430.690.53-0.84
TARBP1TAR (HIV-1) RNA binding protein 11.051.310.840.65-1.00
B2MB2 microglobulin1.021.250.680.52-0.84
SERPIND1Serpin family D member 11.021.210.700.54-0.85
PROCProtein C1.001.230.680.53-0.84
MEN1-PanNET micea
8 month12 monthHuman MEN1 cohort
ProteinDescriptionFold-changeaFold-changeaAUCb95% CI
NDC80Kinetochore protein NDC803.584.300.840.64-1.00
DEF8Differentially expressed in FDCP 8 homolog3.583.320.770.60-0.93
SPAG17Sperm associated antigen 171.931.320.820.59-1.00
ATMATM serine/threonine kinase1.541.990.660.50-0.82
IMMTInner membrane mitochondrial protein1.362.950.770.57-0.96
DNAH6Dynein axonemal heavy chain 61.321.550.690.50-0.88
DSPDesmoplakin1.311.570.770.49-1.00
CITCitron Rho-interacting serine/threonine kinase1.226.160.750.56-0.94
C3Complement C31.161.430.670.53-0.82
HRGHistidine rich glycoprotein1.151.240.660.49-0.82
F5Coagulation factor V1.141.260.750.60-0.89
CD79ACluster of differentiation CD79A1.083.220.690.44-0.95
BDP1B double prime 11.072.860.680.53-0.84
SERPINA11Serpin family A member 111.061.440.750.60-0.90
PROS1Coagulation regulator protein S1.061.430.690.53-0.84
TARBP1TAR (HIV-1) RNA binding protein 11.051.310.840.65-1.00
B2MB2 microglobulin1.021.250.680.52-0.84
SERPIND1Serpin family D member 11.021.210.700.54-0.85
PROCProtein C1.001.230.680.53-0.84

Abbreviations: AUC, area under the receiver operating characteristics curve; CI, confidence interval; dpNET, duodenopancreatic neuroendocrine tumor.

aFold change comparing plasma protein levels between cases (Men1fl/flPdx1-CreTg) and control (Men1fl/fl) mice.

bPredictive performance (AUC) for distinguishing cases from respective controls. Cases are defined as patients with MEN1 and liver metastases from a duodenopancreatic neuroendocrine tumor (dpNET). Controls are patients with MEN1 and a nonmetastatic (distant or regional) indolent dpNET or patients with MEN1 without a dpNET or other neuroendocrine tumor.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close